LYTTON LAURENCE W 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 3:14 pm Purchase |
2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 482,430 4.990% |
64,651 (+15.47%) |
Filing |
| 2022-02-14 7:44 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 417,779 6.600% |
-56,621 (-11.94%) |
Filing |
| 2021-02-16 11:26 am Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 474,400 9.990% |
234,138 (+97.45%) |
Filing |
| 2020-06-12 4:09 pm Purchase |
2020-06-05 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 240,262 9.990% |
240,262 (New Position) |
Filing |